Search results
Better COVID Booster Stock: Moderna vs. Pfizer
Motley Fool· 2 years agoModerna (NASDAQ: MRNA) and Pfizer (NYSE: PFE) have generated billions of dollars from their coronavirus vaccines. Moderna and Pfizer both have asked the...
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots?
LA Times via Yahoo News· 2 years agoVials of Pfizer's bivalent COVID-19 vaccine at a manufacturing facility in Kalamazoo, Mich. (Pfizer...
Better Buy: Pfizer vs. Moderna
Motley Fool· 1 year agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) have one big thing in common. Both companies have dominated the coronavirus vaccine market -- and aim to...
Better COVID Stock: Pfizer vs. Moderna
Motley Fool· 2 years agoPfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) both have generated billions of dollars in revenue, thanks to their coronavirus vaccines. Pfizer has fully...
Moderna, Pfizer say updated COVID shots generate strong response vs newer variant
Reuters via AOL· 8 months ago(Reuters) -Moderna and rival Pfizer on Wednesday said their updated COVID-19 vaccines generated...
Pfizer, Moderna Try To Squeeze Blood From A Stone. Why It Probably Won't Work.
Investor's Business Daily· 9 months agoThe biggest names in Covid are updating their vaccines for a fall campaign, but that might not be...
FDA panel unanimously endorses Pfizer and Moderna COVID-19 shots for babies and little kids
Business Insider via Yahoo News· 2 years agoDr. Barry Diener and Ilana Diener hold their three-year-old son, Hudson, during an appointment for a...
Moderna Surges On New Omicron Data, Pulling Pfizer, BioNTech Along For The Ride
Investor's Business Daily· 1 year agoModerna stock popped Monday after the company said its bivalent Covid booster led to a 15-fold jump...
Pfizer/BioNTech say Omicron-based COVID shots improve response vs that variant
Reuters via Yahoo News· 2 years agoPfizer Inc and BioNTech SE said on Saturday that a booster dose of updated versions of their...
Moderna Stock: Bear vs. Bull
Motley Fool· 1 year agoInvestors have gotten used to Moderna (NASDAQ: MRNA) delivering earnings growth. Thanks to its coronavirus vaccine, the biotech has reported billions of...
